Chemotherapy-induced amenorrhea in early breast cancer [4]

Annals of Oncology

Volumn 17, Issue 2, 2006, Pages 352-

  Ferretti, Gia ^a   Carlini, P ^a   Bria, E ^a   Felici, A ^a   Giannarelli, D ^b   Ciccarese, M ^a   Papaldo, P ^a   Fabi, A ^a   Cognetti, F ^a  

^a Department of Medical Oncology Cancer Institute ^*  (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL;

AMENORRHEA; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG INDUCED DISEASE; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS;

AMENORRHEA; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS;

EID: 31544472124     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdj011     Document Type: Letter

References (4)

1. Pagani O, O'Neill A, Castiglione M et al. Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: Results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer 1998; 34: 632-640.
2. Poikonen P, Saarto T, Elomaa I, Joensuu H, Blomqvist C. Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients. Eur J Cancer 2000; 36: 43-48.
3. Vanhuyse M, Fournier C, Bonneterre J. Chemotherapy-induced amenorrhea: influence on disease-free survival and overall survival in receptor-positive premenopausal early breast cancer patients. Ann Oncol 2005; 16: 1283-1288.
4. Martin M, Pienkowski T, Mackey J et al. Adjuvant docetaxel for node-positive breast cancer. New Engl J Med 2005; 352: 2302-2313.